Managing Chronic Kidney Disease and Chemotherapy-Induced Peripheral Neuropathy with Acupuncture and Herbal Medicine: A Case Study

Managing Chronic Kidney Disease and Chemotherapy-Induced Peripheral Neuropathy with Acupuncture and Herbal Medicine: A Case Study

This case study details the treatment of a 59-year-old male with Stage 3B chronic kidney disease (CKD) and chemotherapy-induced peripheral neuropathy of the left limbs using acupuncture and bulk herbs. After 6 weeks of combined acupuncture and herbal treatments, glomerular filtration rate increased...

Full description

Bibliographic Details
Main Author:	Sunny-Kim Barden
Format:	Article
Language:	English
Published:	Medical Association of Pharmacopuncture Institute 2017-04-01
Series:	Journal of Acupuncture & Meridian Studies
Subjects:	chemotherapy-induced peripheral neuropathy chronic kidney disease herbal medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2005290116301406

Similar Items

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Activating autophagy improves paclitaxel-induced peripheral neuropathy in chemotherapy
by: Jin Zhang, et al.
Published: (2024-10-01)

Herbal Decoction Divya-Peedantak-Kwath Alleviates Allodynia and Hyperalgesia in Mice Model of Chemotherapy-Induced Peripheral Neuropathy via Modulation in Cytokine Response
by: Acharya Balkrishna, et al.
Published: (2020-10-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
by: Zhonghang Xu, et al.
Published: (2022-10-01)

Effects of acupuncture-related intervention on chemotherapy-induced peripheral neuropathy and quality of life: An umbrella review
by: Mei-Ling Yeh, et al.
Published: (2025-05-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Acupuncture in the treatment of chemotherapy-induced peripheral neuropathy: a meta-analysis and data mining
by: Limeng Li, et al.
Published: (2024-10-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine
by: Geehoon Chung, et al.
Published: (2022-07-01)

Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
by: Marina Mattar, et al.
Published: (2024-08-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Acupuncture-related interventions improve chemotherapy-induced peripheral neuropathy: A systematic review and network meta-analysis
by: Mei-Ling Yeh, et al.
Published: (2024-08-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01)

Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
by: Sonoko Misawa, et al.
Published: (2023-11-01)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
by: Nobuaki Egashira
Published: (2021-12-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Chemotherapy-Induced Peripheral Neuropathy: Pathophysiology, Diagnosis, and Treatment
by: Ica Justitia, et al.
Published: (2024-07-01)

The role of physical activity against chemotherapy-induced peripheral neuropathy: a narrative review
by: Daniele Diotti, et al.
Published: (2022-04-01)

Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
by: Rozalyn L. Rodwin, et al.
Published: (2022-03-01)

Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
by: Xiaolan Cheng, et al.
Published: (2017-06-01)

Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trial
by: Christine Brunner, et al.
Published: (2024-08-01)

The correlation between vitamin D and the occurrence of peripheral neuropathy induced by paclitaxel chemotherapy
by: Jialei Zhang, et al.
Published: (2024-09-01)

Comparison of Clinical Symptoms and Neurophysiological Findings in Patients With Chemotherapy Induced Peripheral Neuropathy
by: Kye Hee Cho, et al.
Published: (2022-06-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

EFFICACY AND SAFETY OF DULOXETINE IN THE TREATMENT OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: I Putu Eka Widyadharma, et al.
Published: (2021-01-01)

Clinical and demographic profile of peripheral neuropathy in chronic kidney disease in tertiary hospital in Bundelkhand region, Central India
by: Sengar NS, et al.
Published: (2023-01-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials
by: Hao Tian, et al.
Published: (2025-02-01)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
by: Bojana Milutinovic, et al.
Published: (2022-07-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Patricia Teran-Wodzinski, et al.
Published: (2022-04-01)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
by: Nicolas Kerckhove, et al.
Published: (2021-11-01)